Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
retatrutide phase 3 2025 triple agonist glp-1 gip glucagon 3: 28.7% Weight Loss (2026) Eli Lilly's trial of type0:Primary Antibodies Specification:30 mg
Eli Lilly's trial of obesity therapy meets primary endpoint
These complications require immediate medical attention if symptoms develop
type0:Primary Antibodies
Specification:30 mg
Both contain semaglutide as the active ingredient
US$ 26.54
US$ 23.13
US$ 21.57
US$ 28.57
US$ 22.55
US$ 21.42
US$ 25.08
US$ 27.63
US$ 27.37
